Revenue
2009
2010
2011
2012
2013
2022
2023
2024
2025
Filana Therapeutics, Inc. (FLNA)
Price$0.7840Cached quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2014
2015
2016
2019
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | $41.1M | $10.9M | $11.5M | $16.8M | $20.6M |
| Research & development | $26.6M | $69.6M | $89.4M | $68.0M | $24.8M | — | — | $3.0M | $7.6M | $9.2M | $9.1M | $7.3M | $4.9M | $7.6M | $8.3M | $15.7M | $21.1M |
| Operating expenses | $95.4M | $141.4M | $106.0M | $80.0M | $32.9M | $6.4M | $5.0M | $6.7M | $11.9M | $15.0M | $14.2M | $12.4M | $9.8M | $14.8M | $15.0M | $30.5M | $27.3M |
| Operating income | −$95.4M | −$141.4M | −$106.0M | −$80.0M | −$32.9M | −$6.4M | −$5.0M | −$6.7M | −$11.9M | −$15.0M | −$14.2M | −$12.4M | $31.4M | −$3.9M | −$3.5M | −$13.7M | −$6.8M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | 76.28% | −35.79% | −30.60% | −81.52% | −32.85% |
| EBITDA | −$94.5M | −$140.3M | −$104.4M | −$78.7M | −$32.3M | −$6.4M | −$4.9M | −$6.6M | −$11.9M | −$14.9M | −$14.2M | −$12.4M | — | −$3.8M | −$3.4M | −$13.5M | −$6.5M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | −34.66% | −29.18% | −80.14% | −31.60% |
| Net income | −$91.0M | −$24.3M | −$97.2M | −$76.2M | −$32.4M | −$6.3M | −$4.6M | −$6.6M | −$11.9M | −$14.8M | −$14.1M | −$12.4M | $31.5M | −$3.4M | −$2.6M | −$12.0M | −$3.5M |
| Net profit margin | — | — | — | — | — | — | — | — | — | — | — | — | 76.71% | −31.64% | −22.75% | −71.53% | −16.86% |
| Basic EPSper basic share | -$1.88 | -$0.53 | -$2.32 | -$1.90 | -$0.82 | -$0.24 | -$0.27 | -$0.61 | -$1.82 | -$2.28 | -$106.23 | -$92.53 | $239.88 | -$27.42 | -$20.56 | -$95.95 | -$27.42 |
| Diluted EPSper diluted share | -$1.88 | -$1.46 | -$2.32 | -$1.90 | -$0.82 | -$0.24 | -$0.27 | -$0.61 | -$1.82 | -$2.28 | -$106.23 | -$92.53 | $239.88 | -$27.42 | -$20.56 | -$95.95 | -$27.42 |
Owners
Reported shareholders
4.09%of listed shares
VANGUARD CAPITAL MANAGEMENT LLC1.97M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
VANGUARD CAPITAL MANAGEMENT LLC | 4.09%1.97M shares |
TWO SIGMA INVESTMENTS, LP | 3.54%1.71M shares |
MARSHALL WACE, LLP | 3.31%1.6M shares |
BlackRock, Inc. | 3.01%1.45M shares |
Barry Richard | ≈1.94%938.06K shares |
GOLDMAN SACHS GROUP INC | 1.38%668.79K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.27%615.51K shares |
D. E. Shaw & Co., Inc. | 1.00%485.03K shares |
GMT Capital Corp | 0.93%450.1K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.81%389.6K shares |
Squarepoint Ops LLC | 0.66%318.38K shares |
VANGUARD FIDUCIARY TRUST CO | 0.65%315.89K shares |
ACADIAN ASSET MANAGEMENT LLC | 0.61%295.06K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.60%292.02K shares |
GSA CAPITAL PARTNERS LLP | 0.56%269.41K shares |
GROUP ONE TRADING LLC | 0.51%244.01K shares |
STATE STREET CORP | 0.43%209.11K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.27%132.6K shares |
Connor, Clark & Lunn Investment Management Ltd. | 0.27%132.3K shares |
FEDERATED HERMES, INC. | 0.25%119.95K shares |
Percentages use 48.31M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 24, 2025Form 4 | Anderson Robert Eugene JrDirector | BuyCommon Stock | 8.6K | $2.90 | $24.9K | 8.6K |
| Nov 20, 2025Form 4 | Barry RichardPresident & CEO | BuyCommon Stock · indirect | 150.0K | $2.76 | $414.0K | 938.1K |
| Nov 19, 2025Form 4 | Barry RichardPresident & CEO | BuyCommon Stock · indirect | 73.4K | $2.75 | $201.8K | 788.1K |
| Sep 30, 2025Form 4 | Cook Robert ChristopherChief Operating & Legal Office | BuyCommon Stock | 13.7K | $2.91 | $39.9K | 13.7K |
| Sep 22, 2025Form 4 | Barry RichardPresident & CEO | BuyCommon Stock · indirect | 7.2K | $2.28 | $16.4K | 714.7K |